717 online
 
Most Popular Choices
Share on Facebook 43 Printer Friendly Page More Sharing Summarizing
Life Arts   

Glaxo, Myodil and The UK Regulator

By       (Page 2 of 2 pages) Become a premium member to see this article and all articles as one long page.   No comments

ROBERT FIDDAMAN
Message ROBERT FIDDAMAN
Some of the lines sound familiar:

Could the following have been written for Alistair Benbow?

GlaxoSmithKline has every sympathy for people who think they have suffered as a result of the administration of Myodil.

Anybody who suffers side effects of any sort I feel every sympathy for….
Dr. Alastair Benbow Head of European Psychiatry for GlaxoSmithKline 5/11/03

Sounds like a stuck record.

And here is how GlaxoSmithKline defended the symptoms people were suffering on Myodil:

...the symptoms and issues surrounding arachnoiditis are complex, with current medical opinion indicating that people's suffering is most likely due to their original condition

Glaxo's stance on the settlement with Myodil claimants:

In July 1995, after 4 years of legal proceedings over Myodil, Glaxo Wellcome reached a settlement with a group of plaintiffs. This was done without any admission of liability by the company, which took the view that a settlement was more equitable and in the best interests of the parties, not least in terms of the legal costs which would have been incurred.

Quite

You see folks, GlaxoSmithKline have a tainted history of manufacturing bad drugs, drugs that maim, disfigure, drugs that cause one to want to commit suicide.

It appears that the UK Medicines Regulator has a history of not being forthcoming with patient queries/requests too.

GSK are still manufacturing drugs. The Medicines Regulator are still investigating them!

Do YOU trust them?

Next Page  1  |  2

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

ROBERT FIDDAMAN Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Robert Fiddaman is the author of the book, 'The evidence, however, is clear...the Seroxat scandal'. He has been writing about the pharmaceutical industry and medicine regulators for 7 years. His blog, Seroxat Sufferers, has become popular amongst (more...)
 
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter

Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

A Chemical Imbalance - The Serotonin Myth

Billion Dollar Drug Company Law Firm Restructures Connecticut Welfare System

Psychiatric Medication or Play Therapy?

Who Killed Japanese Culture?

Glaxo, Myodil and The UK Regulator

Paxil Study 329 All Over Again?

To View Comments or Join the Conversation:

Tell A Friend